Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Lymphoproliferative Disorders × ferric carboxymaltose × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Classical hematology 1

Conditions

Anemia 6 Colorectal Neoplasms 3 Postoperative Complications 2 Anemia, Iron-Deficiency 2 Adenocarcinoma 2 Stomach Neoplasms 1 Neoplasms 1 Lymphoproliferative Disorders 1

Interventions

ferric carboxymaltose 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01100879 2022-05-09

AOC-MM

Vifor Pharma

Phase 4 Terminated

Classical hematologyLymphoid

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡